Clinical trial
A Phase I Study of ZD1839 and Palliative Thoracic Radiotherapy in Patients With…
NCT00255489 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00255489 |
|---|---|
| Title | A Phase I Study of ZD1839 and Palliative Thoracic Radiotherapy in Patients With Non-small-cell Lung Cancer |
| Official title | A Phase I Study of ZD1839 (Iressa) and Palliative Thoracic Radiotherapy in Patients With Non-small Cell Lung Cancer |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Non-small-cell Lung Cancer |
| Intervention type | Drug, Procedure |
| Interventions | Gefitinib, palliative thoracic radiotherapy |
| Enrollment | 36 |
| Start date | May 1, 2004 |
| Completion | Jun 1, 2006 |
| First posted | Nov 21, 2005 |
| Last update posted | Jan 25, 2011 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: